GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Replek AD (XMAE:REPL) » Definitions » Change In Other Working Capital

Replek AD (XMAE:REPL) Change In Other Working Capital : MKD0 Mil (TTM As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Replek AD Change In Other Working Capital?

Replek AD's Change In Other Working Capital for the quarter that ended in Mar. 2025 was MKD0 Mil. It means Replek AD's Other Working Capital stayed the same from Dec. 2024 to Mar. 2025 .

Replek AD's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was MKD79 Mil. It means Replek AD's Other Working Capital increased by MKD79 Mil from Dec. 2023 to Dec. 2024 .

Replek AD Change In Other Working Capital Historical Data

The historical data trend for Replek AD's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Replek AD Change In Other Working Capital Chart

Replek AD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.41 4.44 68.36 -23.19 79.20

Replek AD Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Replek AD Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MKD0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Replek AD Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Replek AD's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Replek AD Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Replek AD (XMAE:REPL) » Definitions » Change In Other Working Capital
Comparable Companies
ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR NSE:TORNTPHARM BOM:500124 NBIX BOM:543904 BOM:532321
Traded in Other Exchanges
N/A
Address
Kozle 188, Skopje, MKD
Website
https://www.replek.mk
Replek AD is engaged in the development, design and production of generic medicines. The company develops drugs in different pharmaceutical therapeutic categories including anti-platelet, lipid-lowering, atypical antipsychotic, anti-infective, among others. It manufactures drugs in different forms including tablets, capsules, oral solutions, creams and ointments. Its product portfolio consists of Clopidogrel, Atorvastatin, Simvastatin, risperidone, Clarythromycin, Ciprofloxacin, Meloksikam, Risperidon, terazosin, among others. Replek also offers cannabis oil products, food supplements and cosmetics.